Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
KA similar filings
- 10 Feb 23 Entry into a Material Definitive Agreement
- 5 Jan 23 Regulation FD Disclosure
- 30 Dec 22 Termination of a Material Definitive Agreement
- 22 Dec 22 Kineta Completes Reverse Merger with Yumanity Therapeutics
- 16 Dec 22 Other Events
- 15 Dec 22 Completion of Acquisition or Disposition of Assets
- 13 Dec 22 Submission of Matters to a Vote of Security Holders
Filing view
External links
Exhibit 16.1
December 22, 2022
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Kineta, Inc. (formerly known as Yumanity Therapeutics, Inc.) (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of Kineta, Inc. dated December 16, 2022. We agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts